111 related articles for article (PubMed ID: 4809251)
1. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
[No Abstract] [Full Text] [Related]
2. Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs.
Barfknecht CF; Nichols DE; Rusterholz DB; Long JP; Engelbrecht JA; Beaton JM; Bradley RJ; Dyer DC
J Med Chem; 1973 Jul; 16(7):804-8. PubMed ID: 4725926
[No Abstract] [Full Text] [Related]
3. Congeners of DOM: effect of distribution of the evaluation of pharmacologic data.
Barfknecht CF; Caputo JF; Tobin MB; Dyer DC; Standirdge RT; Howell HG; Goodwin WR; Partyka RA; Gylys JA; Cavanagh RL
NIDA Res Monogr; 1978; (22):16-26. PubMed ID: 101880
[No Abstract] [Full Text] [Related]
4. Effects of rigid amphetamine analogs on vascular strips: studies of 2-aminotetrahydronaphthalene and 2-aminoindan derivatives.
Cheng HC; Long JP; Nichols DE; Barfknecht CF; Rusterholz DB
Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):264-73. PubMed ID: 4851775
[No Abstract] [Full Text] [Related]
5. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Dyer DC; Nichols DE; Rusterholz DB; Barfknecht CF
Life Sci; 1973 Oct; 13(7):885-96. PubMed ID: 4766265
[No Abstract] [Full Text] [Related]
6. Effects of psychotomimetics on vascular strips: studies of methoxylated amphetamines and optical isomers of 2,5-dimethoxy-4-methylamphetamine and 2,5-dimethoxy-4-bromoamphetamine.
Cheng HC; Long JP; Nichols DE; Barfknecht CF
J Pharmacol Exp Ther; 1974 Jan; 188(1):114-23. PubMed ID: 4809263
[No Abstract] [Full Text] [Related]
7. [Studies on hallucinogens. IV. Synthesis of 2,5-dimethoxy-4-methylamphetamine (STP) (author's transl)].
Ono M; Shimamine M; Takahashi K
Eisei Shikenjo Hokoku; 1973; 91(0):41-44. PubMed ID: 4800136
[No Abstract] [Full Text] [Related]
8. Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.
Standridge RT; Howell HG; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1976 Dec; 19(12):1400-4. PubMed ID: 1003425
[No Abstract] [Full Text] [Related]
9. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in psychotomimetic phenylalkylamines.
Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
[No Abstract] [Full Text] [Related]
11. Behavioral and neuropharmacological analysis of amphetamine and 2,5-dimethoxy-4-methylamphetamine in rats.
Tilson HA; Baker TG; Chamberlain JH
Psychopharmacologia; 1975 Nov; 44(3):229-39. PubMed ID: 1208759
[TBL] [Abstract][Full Text] [Related]
12. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
13. Effect of 2,5-dimethoxy-4-methylamphetamine on heart and smooth muscle contraction.
Huang JT; Ho BT
J Pharm Pharmacol; 1974 Jan; 26(1):69-70. PubMed ID: 4150941
[No Abstract] [Full Text] [Related]
14. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
Tilson HA; Chamberlain JH; Gylys JA
Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin.
Huang JT; Ho BT
Can J Physiol Pharmacol; 1973 Dec; 51(12):976-80. PubMed ID: 4777246
[No Abstract] [Full Text] [Related]
16. Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole.
Zweig JS; Castagnoli N
J Med Chem; 1974 Jul; 17(7):747-9. PubMed ID: 4836406
[No Abstract] [Full Text] [Related]
17. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
[TBL] [Abstract][Full Text] [Related]
18. The use of rigid analogues to probe hallucinogen receptors.
Nichols DE; Weintraub HJ; Pfister WR; Yim GK
NIDA Res Monogr; 1978; (22):70-83. PubMed ID: 101889
[No Abstract] [Full Text] [Related]
19. The behavioral effects of 2,5-dimethoxy-4-alkyl amphetamines.
Morin RD; Benington F; Mitchell SR; Beaton JM; Bradley RJ; Smythies JR
Experientia; 1975 Jan; 31(1):93-5. PubMed ID: 234850
[No Abstract] [Full Text] [Related]
20. Effect of 2,5-dimethoxy-4-methylamphetamine (DOM, STP) on the uptake and release of 14C-5-hydroxytryptamine by rabbit blood platelets.
Huang JT; Airaksinen MM; Ho BT
Eur J Pharmacol; 1974 Feb; 25(2):251-4. PubMed ID: 4435028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
